News

The U.S. Food and Drug Administration announced it is shifting away from animal testing in the development of monoclonal ...
The FDA is phasing out an animal testing requirement for monoclonal antibody therapies in favor of testing drugs on ...
The Food and Drug Administration (FDA) announced Thursday it plans to phase out animal testing requirements for biological ...
The U.S. Food and Drug Administration is replacing animal testing with human-relevant methods, including artificial ...
The US Food and Drug Administration announced Thursday that it will be phasing out a requirement that monoclonal antibodies ...
The U.S. Food and Drug Administration said on Thursday it plans to replace animal testing in the development of monoclonal ...
Recuresion Pharma (RXRX) stock and other AI-driven biotechs surge as FDA embraces computational models over animal testing ...
The FDA is moving away from requiring animal models for investigational new drug (IND) applications for new monoclonal ...
On Thursday, shares in Charles River Laboratories, a leading contract research organizations that has stirred controversy over its use of non-human primates, plunged 28 percent after the FDA issued ...
The FDA is phasing out animal testing for monoclonal antibody therapies, embracing AI and human-based models. Read more here.
The FDA laid out a three-year roadmap to phase out animal toxicity testing in drug research. In addition to organoids and lab ...